On Friday, Shattuck Labs Inc (NASDAQ: STTK) was 3.80% up from the session before settling in for the closing price of $4.47. A 52-week range for STTK has been $0.69 – $4.89.
Healthcare Sector giant saw their annual sales slid by -20.93% over the last five years. When this article was written, the company’s average yearly earnings per share was at 48.01%. With a float of $49.63 million, this company’s outstanding shares have now reached $63.15 million.
Shattuck Labs Inc (STTK) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Shattuck Labs Inc stocks. The insider ownership of Shattuck Labs Inc is 21.51%, while institutional ownership is 47.55%. The most recent insider transaction that took place on Aug 25 ’25, was worth 5,471,826. In this transaction Director of this company bought 6,306,127 shares at a rate of $0.87, taking the stock ownership to the 5,255,106 shares. Before that another transaction happened on Aug 25 ’25, when Company’s Director bought 6,306,127 for $0.87, making the entire transaction worth $5,471,826. This insider now owns 5,255,106 shares in total.
Shattuck Labs Inc (STTK) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was less than consensus figure (set at -0.32) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.92% during the next five years compared to -20.93% drop over the previous five years of trading.
Shattuck Labs Inc (NASDAQ: STTK) Trading Performance Indicators
You can see what Shattuck Labs Inc (STTK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 293.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.53 in one year’s time.
